
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1043 | 969 | 950 | 965 | 1190 | - |
Fund Return | 4.27% | -3.08% | -4.95% | -1.17% | 3.53% | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU2197358042 | 2.72B | 0.49 | 14.35 | - | ||
Cleome Index USA Equities R EUR Acc | 2.72B | 0.45 | 14.10 | 12.69 | ||
Cleome Index USA Equities Y EUR Acc | 2.72B | 0.28 | 12.89 | 11.80 | ||
Cleome Index USA Equities Z EUR Acc | 2.72B | 0.50 | 14.44 | 13.08 | ||
LU0654531184 | 2.07B | 1.74 | 9.24 | 8.97 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Invesco JapEqAdvantage A EUR H AccE | 61.92B | -1.95 | 10.69 | 6.70 | ||
Invesco JapEqAdvantage C EUR H AccE | 61.92B | -1.82 | 11.66 | 7.54 | ||
LU1482751903 | 440.29M | 1.06 | 12.91 | - | ||
LU1841614867 | 268.25M | 0.91 | 11.92 | - | ||
Morgan Stanley Global Brands CH | 20.13B | 3.42 | 1.88 | 6.04 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 7.34 | 789.09 | -3.56% | |
AstraZeneca | GB0009895292 | 5.01 | 11,392.0 | +1.46% | |
Merck&Co | US58933Y1055 | 4.38 | 86.39 | -0.24% | |
Novo Nordisk B | DK0062498333 | 4.31 | 456.9 | -2.10% | |
Gilead | US3755581036 | 4.29 | 112.39 | +0.45% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review